Protein Z Plasma Levels are Not Elevated in Patients with Non-Arteritic Anterior Ischemic Optic Neuropathy

被引:4
作者
Asproudis, Ioannis [1 ]
Felekis, Taxiarchis L. [1 ]
Gorezis, Spiridon [2 ]
Dova, Lefkothea [3 ]
Dokou, Eleni [3 ]
Vartholomatos, Georgios [2 ]
Aspiotis, Miltiadis [1 ]
Kolaitis, Nikolaos I. [2 ]
机构
[1] Univ Eye Clin Ioannina, Kosti Palama 1, Ioannina 45500, Greece
[2] Epirus Vis Ctr, Ioannina, Greece
[3] Univ Hosp Ioannina, Haematol Lab, Ioannina, Greece
关键词
Protein Z; Non-arteritic anterior ischemic optic neuropathy;
D O I
10.2174/1874364100903010015
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Protein Z is a glycoprotein that acts as a co-factor for the inhibition of activated coagulation factor X. Protein Z circulating in abnormal levels has been associated with increased risk for acute ischemic events. Non-arteritic Anterior Ischemic Optic Neuropathy (N-AION) is caused by acute ischemic infarction of the optic nerve head, supplied by the posterior ciliary arteries. Objectives: The aim was to investigate whether there is an association between N-AION and plasma protein Z levels. Patients and Methods: Twenty-six cases of confirmed N-AION and fifty-two controls were included in the study group. Protein Z was estimated in thawed citrate plasma on both N-AION cases and controls by an enzyme immunoassay. The imprecision of the estimation was satisfactory (CV = 4, 6%). Results: The controls' protein Z values distributed within a range 340 to 4200 ng/ml (median = 1420, mean = 1673, SD = 1040 ng/ml). Patients' protein Z values distributed within a range 420 to 3600 ng/ml (median = 1030, mean = 1520, SD = 939 ng/ml). There was no statistical difference between the two distributions (Independent t-test, p= 0.529). Conclusion: In our study, protein Z levels are not implicated in the pathogenesis of non-arteritic anterior ischemic optic neuropathy (N-AION).
引用
收藏
页码:15 / 19
页数:5
相关论文
共 40 条
[1]   COAGULATION ABNORMALITIES IN ISCHEMIC OPTIC NEUROPATHY [J].
ACHESON, JF ;
SANDERS, MD .
EYE, 1994, 8 :89-92
[2]   Protein Z and protein Z-dependent protease inhibitor - Determinants of levels and risk of venous thrombosis [J].
Al-Shanqeeti, A ;
Vlieg, AV ;
Berntorp, E ;
Rosendaal, FR ;
Broze, GJ .
THROMBOSIS AND HAEMOSTASIS, 2005, 93 (03) :411-413
[3]   PORTAL OBSTRUCTION IN CHILDREN .1. CLINICAL INVESTIGATION AND HEMORRHAGE RISK [J].
ALVAREZ, F ;
BERNARD, O ;
BRUNELLE, F ;
HADCHOUEL, P ;
ODIEVRE, M ;
ALAGILLE, D .
JOURNAL OF PEDIATRICS, 1983, 103 (05) :696-702
[4]  
BECK RW, 1984, OPHTHALMOLOGY, V91, P1334
[5]  
BERI M, 1987, OPHTHALMOLOGY, V94, P1020
[6]   PROGRESSIVE AND RECURRENT NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY [J].
BORCHERT, M ;
LESSELL, S .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1988, 106 (04) :443-449
[7]   Protein Z in patients with pregnancy complications [J].
Bretelle, F ;
Arnoux, D ;
Shojai, R ;
D'Ercole, C ;
Sampol, J ;
Dignat, F ;
Camoin-Jau, L .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 193 (05) :1698-1702
[8]   HUMAN PROTEIN-Z [J].
BROZE, GJ ;
MILETICH, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (04) :933-938
[9]  
Broze GJ, 2001, THROMB HAEMOSTASIS, V86, P8
[10]   Low protein Z plasma levels are independently associated with acute coronary syndromes [J].
Fedi, S ;
Sofi, F ;
Brogi, D ;
Tellini, I ;
Cesari, F ;
Sestini, I ;
Gazzini, A ;
Comeglio, M ;
Abbate, R ;
Gensini, GF .
THROMBOSIS AND HAEMOSTASIS, 2003, 90 (06) :1173-1178